PDA

View Full Version : GSK explores new avenues for JAK drug in $1.9B Sierra buy amid pending FDA decision - FierceBiotech


RetromanIE
12-12-2022, 20:56
<a href="https://news.google.com/__i/rss/rd/articles/CBMicGh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3 RlY2gvZ3NrLWV4cGxvcmVzLW5ldy1hdmVudWVzLWphay1kcnVn LTE5Yi1zaWVycmEtYnV5LWFtaWQtcGVuZGluZy1mZGEtZGVjaX Npb27SAQA?oc=5" target="_blank">GSK explores new avenues for JAK drug in $1.9B Sierra buy amid pending FDA decision</a>&nbsp;&nbsp;<font color="#6f6f6f">FierceBiotech</font>

More... (https://news.google.com/__i/rss/rd/articles/CBMicGh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3 RlY2gvZ3NrLWV4cGxvcmVzLW5ldy1hdmVudWVzLWphay1kcnVn LTE5Yi1zaWVycmEtYnV5LWFtaWQtcGVuZGluZy1mZGEtZGVjaX Npb27SAQA?oc=5)